E7c8f6bf 6c16 4a6e 93c8 E7241b160aa8 01
Copiktra Capsule
Product Images NDC 73116-225
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Copiktra (NDC 73116-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Secura Bio, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
E7c8f6bf 6c16 4a6e 93c8 E7241b160aa8 02
This appears to be a table or a graph showing the number of participants and their status in a medical study. The study compares the efficacy of two different treatments, COPIKTRA and Ofatumumab, for an unspecified condition. It also indicates the number of censored subjects, meaning those whose outcomes were not observed or recorded. However, the text is not clear and some characters are garbled, so the information is inadequate for further description or analysis.*
E7c8f6bf 6c16 4a6e 93c8 E7241b160aa8 03
E7c8f6bf 6c16 4a6e 93c8 E7241b160aa8 04
E7c8f6bf 6c16 4a6e 93c8 E7241b160aa8 05
E7c8f6bf 6c16 4a6e 93c8 E7241b160aa8 06
Copikira is a medication available in capsule form containing 15mg of duvelisib. Each package contains 28 capsules and is to be administered orally twice daily. The package is child-resistant and comes with a medication guide. It should be stored at room temperature between 20°C to 25°C. For more information, visit www.copikira.com or call 1-844-9-SECURA (1-844-973-2872). It is to be dispensed only in the original container.*
E7c8f6bf 6c16 4a6e 93c8 E7241b160aa8 07
E7c8f6bf 6c16 4a6e 93c8 E7241b160aa8 08
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
